Sun, Dec 28, 2014, 1:11 PM EST - U.S. Markets closed


% | $
Quotes you view appear here for quick access.

Sangamo Biosciences Inc. Message Board

  • btimnextmicrosoft btimnextmicrosoft Nov 4, 2013 12:26 PM Flag

    Looks like we have a product

    We observed that:
    Treatment of HIV subjects with a single infusion of SB-728-T leads to long-term increases in CD4 counts (up to 3 years in some subjects)
    Long-term increases in CD4 counts correlate with increased CD4 central memory, memory stem cells (TSCM)-like and increased ZFN CCR5 protected central memory T-cells
    Seven of nine subjects show decreased levels of HIV DNA at Month 12 post infusion
    An inflammatory environment pre-infusion appears to be an important predictor of CD4 reconstitution post-infusion
    Higher levels of inflammation correlate with poor immunological response and suggest a mechanism for altered survival of CM cells

    SortNewest  |  Oldest  |  Most Replied Expand all replies
14.63+0.43(+3.03%)Dec 26 4:00 PMEST

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.